Cargando…

The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial

OBJECTIVE: This study was designed to compare the efficacy and safety of enteral supplementation of a prebiotic mixture ((SC)GOS/(LC)FOS) on faecal microbiota in very premature infants who fed exclusively with human-milk. METHODS: This double-center randomized control trial was conducted from Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Armanian, Amir-Mohammad, Sadeghnia, Alireza, Hoseinzadeh, Maryam, Mirlohi, Maryam, Feizi, Awat, Salehimehr, Nima, Torkan, Moloud, Shirani, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776544/
https://www.ncbi.nlm.nih.gov/pubmed/26985433
http://dx.doi.org/10.4103/2279-042X.176558
_version_ 1782419160111775744
author Armanian, Amir-Mohammad
Sadeghnia, Alireza
Hoseinzadeh, Maryam
Mirlohi, Maryam
Feizi, Awat
Salehimehr, Nima
Torkan, Moloud
Shirani, Zahra
author_facet Armanian, Amir-Mohammad
Sadeghnia, Alireza
Hoseinzadeh, Maryam
Mirlohi, Maryam
Feizi, Awat
Salehimehr, Nima
Torkan, Moloud
Shirani, Zahra
author_sort Armanian, Amir-Mohammad
collection PubMed
description OBJECTIVE: This study was designed to compare the efficacy and safety of enteral supplementation of a prebiotic mixture ((SC)GOS/(LC)FOS) on faecal microbiota in very premature infants who fed exclusively with human-milk. METHODS: This double-center randomized control trial was conducted from December 2012 to November 2013 in the tertiary Neonatal Intensive Care Units of the Isfahan University of Medical Sciences. Fifty preterm infants (birth weight ≤1500 g who were not fed with formula) were randomly allocated to have enteral (tube feeding) supplementation with a prebiotic mixture ((SC)GOS/(LC)FOS; 9:1) or receive no prebiotics. FINDINGS: The primary outcome (e.g., the effect of the prebiotic mixture on fecal microbiota pattern) was clearly different between the two groups. Despite greater coliforms colony counts in first stool cultures in the prebiotic group (Group P) (P = 0.67), coliforms were significantly lower in the third stool cultures in the Group P (P < 0.001). Furthermore, despite the much higher Lactobacillus colony counts, in the first stool cultures, in the control group (Group C) (P = 0.005); there was a trend toward significantly increased Lactobacillus colony counts in the Group P during the study, but the difference between Lactobacillus colony counts, in the third stool cultures, between two groups was no longer statistically significant (P = 0.11). Interestingly, the median length of hospital stay was significantly less in the Group P (16 [12.50–23.50] vs. 25 [19.50–33.00] days; P = 0.003). CONCLUSION: This suggests that it might have been “the complete removal of formula” which manifests a synergistic effect between nonhuman neutral oligosaccharides (prebiotics) and human oligosaccharides, which in turn, led to the rapid growth of beneficial Lactobacillus colonies in the gut of breast milk-fed preterm infants, while decreasing the number of pathogenic coliforms microorganisms. Therefore, further studies with larger sample sizes are recommended to investigate the issue.
format Online
Article
Text
id pubmed-4776544
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47765442016-03-16 The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial Armanian, Amir-Mohammad Sadeghnia, Alireza Hoseinzadeh, Maryam Mirlohi, Maryam Feizi, Awat Salehimehr, Nima Torkan, Moloud Shirani, Zahra J Res Pharm Pract Original Article OBJECTIVE: This study was designed to compare the efficacy and safety of enteral supplementation of a prebiotic mixture ((SC)GOS/(LC)FOS) on faecal microbiota in very premature infants who fed exclusively with human-milk. METHODS: This double-center randomized control trial was conducted from December 2012 to November 2013 in the tertiary Neonatal Intensive Care Units of the Isfahan University of Medical Sciences. Fifty preterm infants (birth weight ≤1500 g who were not fed with formula) were randomly allocated to have enteral (tube feeding) supplementation with a prebiotic mixture ((SC)GOS/(LC)FOS; 9:1) or receive no prebiotics. FINDINGS: The primary outcome (e.g., the effect of the prebiotic mixture on fecal microbiota pattern) was clearly different between the two groups. Despite greater coliforms colony counts in first stool cultures in the prebiotic group (Group P) (P = 0.67), coliforms were significantly lower in the third stool cultures in the Group P (P < 0.001). Furthermore, despite the much higher Lactobacillus colony counts, in the first stool cultures, in the control group (Group C) (P = 0.005); there was a trend toward significantly increased Lactobacillus colony counts in the Group P during the study, but the difference between Lactobacillus colony counts, in the third stool cultures, between two groups was no longer statistically significant (P = 0.11). Interestingly, the median length of hospital stay was significantly less in the Group P (16 [12.50–23.50] vs. 25 [19.50–33.00] days; P = 0.003). CONCLUSION: This suggests that it might have been “the complete removal of formula” which manifests a synergistic effect between nonhuman neutral oligosaccharides (prebiotics) and human oligosaccharides, which in turn, led to the rapid growth of beneficial Lactobacillus colonies in the gut of breast milk-fed preterm infants, while decreasing the number of pathogenic coliforms microorganisms. Therefore, further studies with larger sample sizes are recommended to investigate the issue. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4776544/ /pubmed/26985433 http://dx.doi.org/10.4103/2279-042X.176558 Text en Copyright: © Journal of Research in Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Armanian, Amir-Mohammad
Sadeghnia, Alireza
Hoseinzadeh, Maryam
Mirlohi, Maryam
Feizi, Awat
Salehimehr, Nima
Torkan, Moloud
Shirani, Zahra
The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial
title The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial
title_full The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial
title_fullStr The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial
title_full_unstemmed The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial
title_short The effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: A randomized clinical trial
title_sort effect of neutral oligosaccharides on fecal microbiota in premature infants fed exclusively with breast milk: a randomized clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776544/
https://www.ncbi.nlm.nih.gov/pubmed/26985433
http://dx.doi.org/10.4103/2279-042X.176558
work_keys_str_mv AT armanianamirmohammad theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT sadeghniaalireza theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT hoseinzadehmaryam theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT mirlohimaryam theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT feiziawat theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT salehimehrnima theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT torkanmoloud theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT shiranizahra theeffectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT armanianamirmohammad effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT sadeghniaalireza effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT hoseinzadehmaryam effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT mirlohimaryam effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT feiziawat effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT salehimehrnima effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT torkanmoloud effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial
AT shiranizahra effectofneutraloligosaccharidesonfecalmicrobiotainprematureinfantsfedexclusivelywithbreastmilkarandomizedclinicaltrial